NasdaqGS - Nasdaq Real Time Price USD

ICU Medical, Inc. (ICUI)

Compare
116.31 +1.45 (+1.26%)
As of 1:21 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
2,257,132.00
2,259,126.00
2,279,997.00
1,316,308.00
1,271,004.00
--
Cost of Revenue
1,524,056.00
1,519,253.00
1,582,236.00
824,818.00
809,507.00
--
Gross Profit
733,076.00
739,873.00
697,761.00
491,490.00
461,497.00
--
Operating Expense
699,203.00
692,037.00
701,329.00
350,208.00
325,926.00
--
Operating Income
33,873.00
47,836.00
-3,568.00
141,282.00
135,571.00
--
Net Non Operating Interest Income Expense
-96,476.00
-95,219.00
-66,375.00
1,982.00
1,924.00
--
Other Income Expense
-39,075.00
-30,916.00
-44,466.00
-20,078.00
-40,001.00
--
Pretax Income
-101,678.00
-78,299.00
-114,409.00
123,186.00
97,494.00
--
Tax Provision
-42,364.00
-48,644.00
-40,123.00
20,051.00
10,624.00
--
Net Income Common Stockholders
-59,314.00
-29,655.00
-74,286.00
103,135.00
86,870.00
--
Diluted NI Available to Com Stockholders
-59,314.00
-29,655.00
-74,286.00
103,135.00
86,870.00
--
Basic EPS
-2.45
-1.23
-3.11
4.86
4.16
--
Diluted EPS
-2.45
-1.23
-3.11
4.74
4.02
--
Basic Average Shares
24,143.00
24,091.00
23,868.00
21,206.00
20,907.00
--
Diluted Average Shares
24,143.00
24,091.00
23,868.00
21,781.00
21,591.00
--
Total Operating Income as Reported
2,775.00
22,825.00
-42,898.00
123,245.00
98,162.00
--
Total Expenses
2,223,259.00
2,211,290.00
2,283,565.00
1,175,026.00
1,135,433.00
--
Net Income from Continuing & Discontinued Operation
-59,314.00
-29,655.00
-74,286.00
103,135.00
86,870.00
--
Normalized Income
-36,098.20
-5,100.22
-43,352.06
120,465.09
125,016.38
--
Interest Income
8,402.00
7,508.00
4,430.00
2,840.00
3,677.00
--
Interest Expense
104,878.00
102,727.00
70,805.00
858.00
1,753.00
--
Net Interest Income
-96,476.00
-95,219.00
-66,375.00
1,982.00
1,924.00
--
EBIT
3,200.00
24,428.00
-43,604.00
124,044.00
99,247.00
--
EBITDA
231,774.00
253,202.00
191,547.00
213,742.00
184,878.00
--
Reconciled Cost of Revenue
1,524,056.00
1,519,253.00
1,582,236.00
824,818.00
809,507.00
--
Reconciled Depreciation
228,574.00
228,774.00
235,151.00
89,698.00
85,631.00
--
Net Income from Continuing Operation Net Minority Interest
-59,314.00
-29,655.00
-74,286.00
103,135.00
86,870.00
--
Total Unusual Items Excluding Goodwill
-38,693.00
-31,082.00
-47,664.00
-20,705.00
-42,813.00
--
Total Unusual Items
-38,693.00
-31,082.00
-47,664.00
-20,705.00
-42,813.00
--
Normalized EBITDA
270,467.00
284,284.00
239,211.00
234,447.00
227,691.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-15,477.20
-6,527.22
-16,730.06
-3,374.92
-4,666.62
--
12/31/2019 - 3/31/1992

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MMSI Merit Medical Systems, Inc.
82.54
-0.26%
 
HAE Haemonetics Corporation
82.94
-0.58%
 
ANGO AngioDynamics, Inc.
5.79
+1.94%
 
UTMD Utah Medical Products, Inc.
67.21
+0.24%
 
LMAT LeMaitre Vascular, Inc.
82.12
+0.29%
 
NVST Envista Holdings Corporation
16.28
+1.75%
 
STVN Stevanato Group S.p.A.
17.04
-1.05%
 
TFX Teleflex Incorporated
201.18
+1.29%
 
ATRI Atrion Corporation
453.15
+0.15%
 
XRAY DENTSPLY SIRONA Inc.
25.04
+0.12%